Global Oncology Companion Diagnostics Market 2022-2028
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global oncology companion diagnostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the oncology companion diagnostics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the solution, technology, indication, end user, and region. The global market for oncology companion diagnostics can be segmented By solution: consumables, instruments, services. Oncology companion diagnostics market is further segmented By technology: immunohistochemistry (IHC), polymerase chain reaction (PCR), next-generation sequencing (NGS), others. Based on indication, the oncology companion diagnostics market is segmented into: breast cancer, colorectal cancer, gastric cancer, lung cancer, melanoma, others. On the basis of end user, the oncology companion diagnostics market also can be divided into: contract research organization (CRO), laboratories, pharmaceutical & biopharmaceutical companies, others. Oncology companion diagnostics market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By solution:
- consumables
- instruments
- services
By technology:
- immunohistochemistry (IHC)
- polymerase chain reaction (PCR)
- next-generation sequencing (NGS)
- others
By indication:
- breast cancer
- colorectal cancer
- gastric cancer
- lung cancer
- melanoma
- others
By end user:- contract research organization (CRO)
- laboratories
- pharmaceutical & biopharmaceutical companies
- others
By region:
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)
The report explores the recent developments and profiles of key vendors in the Global Oncology Companion Diagnostics Market, including Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche Ltd., Foundation Medicine, Inc., Guardant Health, Inc., ICON plc, Illumina, Inc., Invitae Corporation, Invivoscribe Technologies, Inc., Myriad Genetics, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global oncology companion diagnostics market.
- To classify and forecast the global oncology companion diagnostics market based on solution, technology, indication, end user, region.
- To identify drivers and challenges for the global oncology companion diagnostics market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global oncology companion diagnostics market.
- To identify and analyze the profile of leading players operating in the global oncology companion diagnostics market.
Why Choose This Report
- Gain a reliable outlook of the global oncology companion diagnostics market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY SOLUTION
Consumables
Instruments
Services
PART 6. MARKET BREAKDOWN BY TECHNOLOGY
Immunohistochemistry (IHC)
Polymerase chain reaction (PCR)
Next-generation sequencing (NGS)
Others
PART 7. MARKET BREAKDOWN BY INDICATION
Breast cancer
Colorectal cancer
Gastric cancer
Lung cancer
Melanoma
Others
PART 8. MARKET BREAKDOWN BY END USER
Contract research organization (CRO)
Laboratories
Pharmaceutical & biopharmaceutical companies
Others
PART 9. MARKET BREAKDOWN BY REGION
North America
Asia Pacific
Europe
Rest of the World (ROW)
PART 10. KEY COMPANIES
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
bioMerieux SA
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Foundation Medicine, Inc.
Guardant Health, Inc.
ICON plc
Illumina, Inc.
Invitae Corporation
Invivoscribe Technologies, Inc.
Myriad Genetics, Inc.
Qiagen N.V.
Quest Diagnostics Incorporated
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
USD 7500 View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
USD 2450 View ReportGlobal Oncology/Cancer Drugs Market Research Report
Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors
USD View ReportGlobal Oncology Ablation Market Research Report
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Oncology Ablation Report by Material, Application, and Geography Global Forecast
USD View ReportFill The Form For Sample Request